Epithalon (Ala-Glu-Asp-Gly) is a synthetic tetrapeptide developed by Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology. Research has focused on its ability to activate telomerase, elongate telomeres in somatic cells, regulate pineal gland function, and extend lifespan in animal models.
Telomere Biology and Aging
Telomeres are repetitive DNA sequences found at the ends of chromosomes that protect them from degradation. They progressively shorten with each cell division, and when critically short, cells enter senescence or apoptosis. Telomere length is considered a molecular marker of cellular aging, making telomerase activation a key target in longevity research.
Telomerase Activation Research
Studies by Khavinson's group have reported that Epithalon can activate telomerase in somatic cells, leading to telomere elongation. In vitro studies demonstrated this effect in human fetal fibroblasts, and animal studies in rodents reported extended lifespan and delayed age-related pathology in treated groups compared to controls.
Pineal Gland and Melatonin Research
Epithalon is derived from a preparation called Epithalamin, originally extracted from bovine pineal glands. Research suggests it may support pineal gland function, potentially influencing melatonin synthesis — a hormone with known antioxidant and circadian regulatory roles that declines significantly with age.
Limitations and Scientific Considerations
The majority of Epithalon research originates from a small cluster of affiliated Russian institutions. Independent large-scale replication in Western research settings remains limited. Human clinical data is sparse compared to the volume of preclinical evidence.
Research Disclaimer: This article is for educational purposes only and does not constitute medical advice.